Stevens Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,585	Closed	-$218K	–	92
2019 Q4	$218K	Buy	+3,585	New	+$218K	0.02%	516